Barry D. Dickinson PhD

Barry D. Dickinson, PhD, is Director of Science, Medicine & Public Health at the American Medical Association (AMA) in Chicago, Il. This department provides content expertise for the association on drug policy, genomics and precision medicine, and selected topics in public health including vaccine policy, antimicrobial stewardship and infectious diseases, injury prevention and environmental science. He served for 20 years as the Secretary for the AMA's Council on Science and Public Health, and more recently as the AMA's representative to the National Council for Patient Information and Education, and the National Coordinating Council for Medication Error Reporting and Prevention.

Dr. Dickinson also serves as the AMA delegate to the United States Pharmacopeia Convention, retains an adjunct faculty appointment in Pharmacology at the Rosalind Franklin University of Medicine and Science, and is currently a co-staff lead for the AMA's Opioid Task Force. For the last 6 years he has been principal investigator for the AMA's activities under the Provider's Clinical Support System for Opioid Therapies, funded by SAMHSA, and administered by the American Academy of Addiction Psychiatry (www.pcss-o.org).